Literature DB >> 8565170

Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials.

C M Pratt1, P S Greenway, M H Schoenfeld, M L Hibben, J A Reiffel.   

Abstract

BACKGROUND: As cardiovascular clinical trials improve in sophistication and therapies target specific cardiac mechanisms of death, a more objective and precise system to identify specific cause of death is needed. Ideally, sudden cardiac death would describe patients dying of ventricular tachycardia and ventricular fibrillation. In this context, we explored the precision of current sudden death classification and implications for clinical trials. METHODS AND
RESULTS: Deaths were analyzed in 834 patients who received an automatic implantable cardioverter-defibrillator (ICD). Three arrhythmia experts used a standard prospective classification system to classify deaths into accepted categories: sudden cardiac, nonsudden cardiac, and noncardiac. New aspects to this study included analysis of autopsy results and ICD interrogation for arrhythmias at the time of death. All of the patients receiving the ICD previously had documented sustained ventricular tachycardia/fibrillation or cardiac arrest. Of the 109 subsequent deaths in the 834-patient database, 17 (16%) were classified as sudden cardiac. Compared with the nonsudden cardiac and noncardiac categories, sudden cardiac death was more often identified in outpatients (59% versus 10%) and witnessed less often (41% versus 86%; both P < .001). The autopsy information contradicted and changed the clinical perception of a "sudden cardiac death" in 7 cases (myocardial infarction [n = 1], pulmonary embolism [n = 2], cerebral infarction [n = 1], ruptured thoracic [n = 1], and abdominal aortic aneurysms [n = 2]). Interpretable ICD interrogation was available in 53% of the deaths (47% unavailable: buried, programmed off, or other technical reasons). When evaluated, only 7 of 17 "sudden deaths" were associated with ICD discharges near the time of death.
CONCLUSIONS: Even in a group of patients with an ICD, deaths classified as sudden cardiac frequently were not associated with ventricular tachycardia or ventricular fibrillation and were often noncardiac. It is possible to create a wide range of sudden cardiac death rates (more than fourfold) using the identical clinical database despite objective, prespecified criteria. Autopsy results frequently reveal noncardiac causes of clinical events simulating sudden cardiac death. ICD interrogation revealed that ICD discharges were often related to terminal arrhythmias incidental to the primary pathophysiological process leading to death.

Entities:  

Mesh:

Year:  1996        PMID: 8565170     DOI: 10.1161/01.cir.93.3.519

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

Review 1.  Antiarrhythmic therapies for the prevention of sudden cardiac death.

Authors:  F A McAlister; K K Teo
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Years of Life and Productivity Loss Because of Adult Sudden Unexpected Death in the United States.

Authors:  Mojtaba Mirzaei; Golsa Joodi; Brittany Bogle; Sarah Chen; Ross J Simpson
Journal:  Med Care       Date:  2019-07       Impact factor: 2.983

Review 3.  Sudden cardiac death: epidemiology and risk factors.

Authors:  A Selcuk Adabag; Russell V Luepker; Véronique L Roger; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2010-02-09       Impact factor: 32.419

4.  QRS width and its impact on inducibility of ventricular arrhythmia at the time of electrophysiology study.

Authors:  Mahi Lakshmi Ashwath; Ike Okosun; Felix O Sogade
Journal:  J Natl Med Assoc       Date:  2005-05       Impact factor: 1.798

Review 5.  Neurohormonal intervention to reduce sudden cardiac death in heart failure: what is the optimal pharmacologic strategy?

Authors:  Iain Squire
Journal:  Heart Fail Rev       Date:  2004-10       Impact factor: 4.214

Review 6.  Preventing sudden death in the adult with congenital heart disease.

Authors:  Ronn E Tanel
Journal:  Curr Cardiol Rep       Date:  2011-08       Impact factor: 2.931

Review 7.  The interplay between CKD, sudden cardiac death, and ventricular arrhythmias.

Authors:  Patrick H Pun
Journal:  Adv Chronic Kidney Dis       Date:  2014-10-24       Impact factor: 3.620

8.  ECG quantification of myocardial scar and risk stratification in MADIT-II.

Authors:  Zak Loring; Wojciech Zareba; Scott McNitt; David G Strauss; Galen S Wagner; James P Daubert
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-06-09       Impact factor: 1.468

9.  Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT).

Authors:  John D Fisher; Alfred E Buxton; Kerry L Lee; Douglas L Packer; Debra S Echt; Pablo Denes; Michael H Lehmann; John P DiMarco; Denis Roy; Gail E Hafley
Journal:  Am J Cardiol       Date:  2007-05-11       Impact factor: 2.778

10.  Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study.

Authors:  Mihael Potocki; Tobias Breidthardt; Tobias Reichlin; Nils G Morgenthaler; Andreas Bergmann; Markus Noveanu; Nora Schaub; Heiko Uthoff; Heike Freidank; Lorenz Buser; Roland Bingisser; Michael Christ; Alexandre Mebazaa; Christian Mueller
Journal:  Crit Care       Date:  2009-07-23       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.